Drug List for Neurology
Description: Field concerning the nervous system, especially the brain, peripheral nerves, and spinal cord. Studies in this field include: Alzheimer’s Disease, Attention Deficit Hyperactivity Disorder (ADHD), Carpal Tunnel Syndrome, Huntington’s Disease, dementia, memory loss, migraine headaches, multiple sclerosis, muscular dystrophy, Parkinson’s Disease, strokes, Tourette’s Syndrome, and others.
Below the search box are the FDA approved drugs for the Neurology category. Click any link to view the full drug information.
 | |
|
1. Phrase: 2. Area: |
|
|
3. Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |
|
| 4. Show all | |
Results: 91
Back to top
FDA Approved Listings:
The rules of principle for evaluating MediLexicon's FDA Approval Listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.
MediLexicon's FDA Approved Drugs Listings include:
New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.
MediLexicon's FDA Approved Drugs Listings do NOT include:
Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.
Please note that the extra search boxes at the top of the website link to external drug website databases. In no event shall MediLexicon International Ltd be responsible for the content, accuracy or opinions expressed in these web sites.
The Neurology FDA drug information used in this section is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
